HSF1 and melanoma: One of the most potent HSF1 inhibitors, triptolide, was found to inhibit metastasis of B16 mouse melanoma cells [43], but its further pharmacological application is hampered because of toxicity issues; currently, newer triptolide derivatives being studied are exemplified by minnelide, but their function in EMT-mediated phenotypic conversion remains elusive [44].